New Key Statistics Module, Z-Score and F-Score
NAS:NRBO Key Ratios
Market Cap $ M | 19.71 |
Enterprise Value $ M | 2.84 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.96 |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -3.22 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 68.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -0.17 |
EV-to-EBITDA | -0.17 |
PEG | -- |
Shares Outstanding M | 4.91 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 2.46 |
Current Ratio | 2.46 |
ROA % (ttm) | -65.33 |
ROE % (ttm) | -88.18 |
ROIC % (ttm) | -718.39 |
Dividend Yield % | -- |
Altman Z-Score | -- |
NRBO Number of Guru Trades
NRBO Volume of Guru Trades
Gurus Latest Trades with NAS:NRBO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NRBO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NeuroBo Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:NRBO
Total 0- 1